Page 1

DAILY REPORT 21th MAY

Straits Times Index (STI)

Snapshot for Straits Times Index STI (FSSTI) Open

3,260.49

Previous Close

3,262.43

Day Range

3,250.14 – 3,268.75

Year-to- Date

+4.59%

1-Year

-2.52%

52-Week Range

2953.01-3464.79 TOP GAINERS & LOSERS

TOP GAINERS 3.50%

TOP GAINER

% Change

3.00% 2.50%

ComfortDelGro Corp L...

+3.03%

Singapore Telecommun...

+0.78%

2.00%

Singapore Press Hold...

+0.47%

1.50%

Hongkong Land Holdin...

+0.43%

1.00%

City Developments Lt...

+0.39%

0.50%

Genting Singapore PL...

+0.37%

United Overseas Bank...

+0.35%

Singapore Exchange L...

+0.29%

0.00%

CD

ST

SPH

HKL

CIT

GENS UOB

SGX

CMA

JS

% Change 3.03% 0.78% 0.47% 0.43% 0.39% 0.37% 0.35% 0.29% 0.00% 0.00%

TOP LOOSERS

CapitaMalls Asia Ltd

0.00%

Jardine Strategic Ho...

0.00%

TOP LOSER

0.00%

% Change

Wilmar International...

-0.93%

Golden Agri-Resource...

-0.87%

-0.40%

Thai Beverage PCL

-0.83%

-0.50%

Singapore Airlines L...

-0.78%

Noble Group Ltd

-0.76%

Sembcorp Marine Ltd

-0.75%

Jardine Matheson Hol...

-0.66%

Oversea-Chinese Bank...

-0.21%

-0.10% -0.20% -0.30%

-0.60% -0.70% -0.80% -0.90% -1.00% WIL

THBE GGR V

STA

NOB SMM AL

JM

OCBC

CT

GLP

%Change -0.93 -0.87 -0.83 -0.78 -0.76 -0.75 -0.66 -0.21 0.00% 0.00%

YOUR MINTVISORY

CapitaMall Trust

0.00%

Global Logistic Prop...

0.00% Page 1


DAILY REPORT 21th MAY

MARKET UPDATES & STOCK RECOMMENDATION Singapore's Goodpack Ltd confirmed on Tuesday it is in discussions with KKR & Co about a possible buyout by the US private equity firm, the company said in a statement. The announcement follows reports on Monday that KKR was nearing the deal. If successful, the purchase of Goodpack would be KKR's first purchase of a listed company from its latest Asia fund,

SMRT CORPORATION

IE Singapore and the Nanjing Health Bureau plan to facilitate exchanges between Singapore and Nanjing's public and private sectors to encourage collaboration in the healthcare sector. Both parties will identify and support a commercially-driven, demonstrative healthcare platform project spanning different sectors such as master-planning, smart healthcare solutions and healthcare and wellness services. SHARES of Valuetronics extended gains on Tuesday. PhillipCapital on Tuesday initiated coverage on the integrated electronics manufacturing service provider, with a "buy" rating and a target price of 43 Singapore cents, representing a potential 28 per cent upside.

BUY SMRT CORPORATION ABOVE 1.480 TG 1.520, 1.560, 1.620 SL 1.420

Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. We are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.

Give us a missed call at +6531581402 YOUR MINTVISORY

Visit us @ www.epicresearch.sg Page 2


Daily sgx sinagpore report by epic research singapore 21st may 2014  

Epic Research private limited have best technical research team, Our research team provide Daily report on SGX Singapore and SGX Exchange, Y...

Advertisement
Read more
Read more
Similar to
Popular now
Just for you